Skip to main content
Erschienen in: Clinical Rheumatology 12/2009

01.12.2009 | Brief Report

Correlation of synovial fluid leptin concentrations with the severity of osteoarthritis

verfasst von: Jung Hoei Ku, Choon Key Lee, Bo Sun Joo, Byeong Min An, Seung Hyun Choi, Tae Hyun Wang, Hyung Lae Cho

Erschienen in: Clinical Rheumatology | Ausgabe 12/2009

Einloggen, um Zugang zu erhalten

Abstract

Leptin is known to play an important role in the pathophysiology of osteoarthritis (OA). This study investigated whether synovial fluid (SF) leptin level is related to the radiographic severity of OA and its role as a quantitative marker for the detection of OA. SF was obtained from 42 OA patients who underwent knee surgery and 10 who had no abnormality of articular cartilage during arthroscopic examination. The progression of OA was classified by Kellgren–Lawrence grading scale. The concentrations of leptin were measured with commercial enzyme-linked-immunosorbent serologic assay kits. Median leptin concentrations in SF were significantly higher in OA patients (median 4.40 ng/ml; range 0.5–15.8) compared to controls (median 2.05 ng/ml; range 1.0–4.6; P = 0.006). SF leptin levels showed significant difference according to the severity of OA (P = 0.0125). Median SF leptin level was highest in stage IV patients (11.1 ng/ml), which was significantly higher compared to all other groups including controls (P < 0.05). Age showed a significant positive correlation with leptin concentrations in OA patients (P < 0.05), but not in controls. These results demonstrate that SF leptin concentrations were closely related to the radiographic severity of OA, suggesting that SF leptin levels could be used as an effective marker for quantitative detection of OA.
Literatur
1.
Zurück zum Zitat Garnero P, Landewe R, Boers M et al (2002) Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum 11:2847–2856CrossRef Garnero P, Landewe R, Boers M et al (2002) Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum 11:2847–2856CrossRef
2.
Zurück zum Zitat Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502CrossRefPubMed Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502CrossRefPubMed
3.
Zurück zum Zitat Dahlberg L, Ryd L, Heinegard D, Lohmander LS (2003) Proteoglycan fragments in joint fluid. Influence of arthrosis and inflammation. Acta Orthop Scand 4:417–423 Dahlberg L, Ryd L, Heinegard D, Lohmander LS (2003) Proteoglycan fragments in joint fluid. Influence of arthrosis and inflammation. Acta Orthop Scand 4:417–423
4.
Zurück zum Zitat Maiotti M, Monteleone G, Tarantino U, Fasciglione GF, Marini S, Coletta M (2000) Correlation between osteoarthritic cartilage damage and levels of proteinases and proteinase inhibitors in synovial fluid from the knee joint. Arthroscopy 5:522–526CrossRef Maiotti M, Monteleone G, Tarantino U, Fasciglione GF, Marini S, Coletta M (2000) Correlation between osteoarthritic cartilage damage and levels of proteinases and proteinase inhibitors in synovial fluid from the knee joint. Arthroscopy 5:522–526CrossRef
5.
Zurück zum Zitat Takahashi M, Naito K, Abe M, Sawada T, Nagano A (2004) Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther 3:R208–R212CrossRef Takahashi M, Naito K, Abe M, Sawada T, Nagano A (2004) Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther 3:R208–R212CrossRef
6.
Zurück zum Zitat Chambers MG, Bayliss MT, Mason RM (1997) Chondrocyte cytokine and growth factor expression in murine osteoarthritis. Osteoarthritis Cartilage 5:301–308CrossRefPubMed Chambers MG, Bayliss MT, Mason RM (1997) Chondrocyte cytokine and growth factor expression in murine osteoarthritis. Osteoarthritis Cartilage 5:301–308CrossRefPubMed
7.
Zurück zum Zitat Goldenberg MM (1999) Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis. Clin Ther 1:75–87CrossRef Goldenberg MM (1999) Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis. Clin Ther 1:75–87CrossRef
8.
Zurück zum Zitat Webb GR, Westacott CI, Elson CJ (1997) Chondrocyte tumor necrosis factor receptors and focal loss of cartilage in osteoarthritis. Osteoarthritis Cartilage 6:427–437CrossRef Webb GR, Westacott CI, Elson CJ (1997) Chondrocyte tumor necrosis factor receptors and focal loss of cartilage in osteoarthritis. Osteoarthritis Cartilage 6:427–437CrossRef
9.
Zurück zum Zitat Westacott CI, Sharif M (1996) Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 4:254–272CrossRef Westacott CI, Sharif M (1996) Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 4:254–272CrossRef
10.
Zurück zum Zitat Chehab FF, Mounzih K, Lu R, Lim ME (1997) Early onset of reproductive function in normal female mice treated with leptin. Science 5296:88–90CrossRef Chehab FF, Mounzih K, Lu R, Lim ME (1997) Early onset of reproductive function in normal female mice treated with leptin. Science 5296:88–90CrossRef
11.
Zurück zum Zitat Sierra-Honigmann MR, Nath AK, Murakami C et al (1998) Biological action of leptin as an angiogenic factor. Science 5383:1683–1686CrossRef Sierra-Honigmann MR, Nath AK, Murakami C et al (1998) Biological action of leptin as an angiogenic factor. Science 5383:1683–1686CrossRef
12.
Zurück zum Zitat Figenschau Y, Knutsen G, Shahazeydi S, Johansen O, Sveinbjornsson B (2001) Human articular chondrocytes express functional leptin receptors. Biochem Biophys Res Commun 287:190–197CrossRefPubMed Figenschau Y, Knutsen G, Shahazeydi S, Johansen O, Sveinbjornsson B (2001) Human articular chondrocytes express functional leptin receptors. Biochem Biophys Res Commun 287:190–197CrossRefPubMed
13.
Zurück zum Zitat Dumond H, Presle N, Terlain B et al (2003) Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 11:3118–3129CrossRef Dumond H, Presle N, Terlain B et al (2003) Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 11:3118–3129CrossRef
14.
Zurück zum Zitat Van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB (2000) Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthritis Cartilage 1:25–33CrossRef Van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB (2000) Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthritis Cartilage 1:25–33CrossRef
15.
Zurück zum Zitat Redini F, Mauviel A, Pronost S, Loyau G, Pujol JP (1993) Transforming growth factor beta exerts opposite effects from interleukin-1 beta on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. Arthritis Rheum 1:44–50CrossRef Redini F, Mauviel A, Pronost S, Loyau G, Pujol JP (1993) Transforming growth factor beta exerts opposite effects from interleukin-1 beta on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. Arthritis Rheum 1:44–50CrossRef
16.
Zurück zum Zitat Teichtahl AJ, Wluka AE, Proietto J, Cicuttini FM (2005) Obesity and the female sex, risk factors for knee osteoarthritis that may be attributable to systemic or local leptin biosynthesis and its cellular effects. Med Hypotheses 65:312–315CrossRefPubMed Teichtahl AJ, Wluka AE, Proietto J, Cicuttini FM (2005) Obesity and the female sex, risk factors for knee osteoarthritis that may be attributable to systemic or local leptin biosynthesis and its cellular effects. Med Hypotheses 65:312–315CrossRefPubMed
17.
Zurück zum Zitat Simopoulou T, Malizos KN, Iliopoulos D et al (2007) Differential expression of leptin and leptin’s receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis Cartilage 8:872–883CrossRef Simopoulou T, Malizos KN, Iliopoulos D et al (2007) Differential expression of leptin and leptin’s receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis Cartilage 8:872–883CrossRef
18.
Zurück zum Zitat Fernandes JC, Martel-Pelletier J, Pelletier JP (2002) The role of cytokines in osteoarthritis pathophysiology. Biorheology 39:237–246PubMed Fernandes JC, Martel-Pelletier J, Pelletier JP (2002) The role of cytokines in osteoarthritis pathophysiology. Biorheology 39:237–246PubMed
19.
Zurück zum Zitat Tetlow LC, Adlam DJ, Woolley DE (2001) Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 3:585–594CrossRef Tetlow LC, Adlam DJ, Woolley DE (2001) Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 3:585–594CrossRef
20.
Zurück zum Zitat Otero M, Gomez Reino JJ, Gualillo O (2003) Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells. Arthritis Rheum 2:404–409CrossRef Otero M, Gomez Reino JJ, Gualillo O (2003) Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells. Arthritis Rheum 2:404–409CrossRef
21.
Zurück zum Zitat Otero M, Lago R, Lago F, Reino JJ, Gualillo O (2005) Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1. Arthritis Res Ther 3:R581–R591CrossRef Otero M, Lago R, Lago F, Reino JJ, Gualillo O (2005) Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1. Arthritis Res Ther 3:R581–R591CrossRef
22.
Zurück zum Zitat Uesaka S, Nakayama Y, Yoshihara K, Ito H (2002) Significance of chondroitin sulfate isomers in the synovial fluid of osteoarthritis patients. J Orthop Sci 2:232–237CrossRef Uesaka S, Nakayama Y, Yoshihara K, Ito H (2002) Significance of chondroitin sulfate isomers in the synovial fluid of osteoarthritis patients. J Orthop Sci 2:232–237CrossRef
23.
Zurück zum Zitat Blum WF, Englaro P, Hanitsch S et al (1997) Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab 9:2904–2910CrossRef Blum WF, Englaro P, Hanitsch S et al (1997) Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab 9:2904–2910CrossRef
24.
Zurück zum Zitat Hickey MS, Israel RG, Gardiner SN et al (1996) Gender differences in serum leptin levels in humans. Biochem Mol Med 1:1–6CrossRef Hickey MS, Israel RG, Gardiner SN et al (1996) Gender differences in serum leptin levels in humans. Biochem Mol Med 1:1–6CrossRef
Metadaten
Titel
Correlation of synovial fluid leptin concentrations with the severity of osteoarthritis
verfasst von
Jung Hoei Ku
Choon Key Lee
Bo Sun Joo
Byeong Min An
Seung Hyun Choi
Tae Hyun Wang
Hyung Lae Cho
Publikationsdatum
01.12.2009
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 12/2009
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1242-8

Weitere Artikel der Ausgabe 12/2009

Clinical Rheumatology 12/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.